Literature DB >> 16936755

pRb2/p130: a new candidate for retinoblastoma tumor formation.

G De Falco1, A Giordano.   

Abstract

Retinoblastoma is the most common primary intraocular tumor in childhood. Mutations in both the alleles of the RB1 gene represent the causative agent for the tumor to occur. It is becoming evident that, although these alterations represent key events in the genesis of retinoblastoma, they are not sufficient per se for the tumor to develop, and other additional genetic or epigenetic alterations must occur. A supportive role in the genesis of retinoblastoma has recently been proposed for the RB1-related gene RB2/p130. Additionally, several other genetic alterations involving different chromosomes have been described as relevant in the tumorigenic process. In this review we will analyse current knowledge about the molecular mechanisms involved in retinoblastoma, paying particular attention to the mechanisms of inactivation of the biological function of the retinoblastoma family of proteins.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16936755     DOI: 10.1038/sj.onc.1209614

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  8 in total

1.  Analysis of retinoblastoma age incidence data using a fully stochastic cancer model.

Authors:  Mark P Little; Ruth A Kleinerman; Charles A Stiller; Guangquan Li; Mary E Kroll; Michael F G Murphy
Journal:  Int J Cancer       Date:  2011-06-10       Impact factor: 7.396

Review 2.  Medulloblastoma: from molecular pathology to therapy.

Authors:  Alessandra Rossi; Valentina Caracciolo; Giuseppe Russo; Krzysztof Reiss; Antonio Giordano
Journal:  Clin Cancer Res       Date:  2008-02-15       Impact factor: 12.531

Review 3.  Molecular biology of retinoblastoma.

Authors:  C Sábado Alvarez
Journal:  Clin Transl Oncol       Date:  2008-07       Impact factor: 3.405

4.  RBL2/p130 is a direct AKT target and is required to induce apoptosis upon AKT inhibition in lung cancer and mesothelioma cell lines.

Authors:  Francesca Pentimalli; Iris M Forte; Luca Esposito; Paola Indovina; Carmelina A Iannuzzi; Luigi Alfano; Caterina Costa; Daniela Barone; Gaetano Rocco; Antonio Giordano
Journal:  Oncogene       Date:  2018-04-02       Impact factor: 9.867

5.  Proteomic profiling of retinoblastoma by high resolution mass spectrometry.

Authors:  Ravikanth Danda; Kalaivani Ganapathy; Gajanan Sathe; Anil K Madugundu; Sharavan Ramachandran; Uma Maheswari Krishnan; Vikas Khetan; Pukhraj Rishi; T S Keshava Prasad; Akhilesh Pandey; Subramanian Krishnakumar; Harsha Gowda; Sailaja V Elchuri
Journal:  Clin Proteomics       Date:  2016-10-26       Impact factor: 3.988

Review 6.  Orchestrating epigenetic roles targeting ocular tumors.

Authors:  Xuyang Wen; Linna Lu; Zhang He; Xianqun Fan
Journal:  Onco Targets Ther       Date:  2016-02-29       Impact factor: 4.147

7.  Mutational screening of germline RB1 gene in Vietnamese patients with retinoblastoma reveals three novel mutations.

Authors:  Ha Hai Nguyen; Hoa Thi Thanh Nguyen; Nhung Phuong Vu; Quynh Thuy Le; Chau Minh Pham; Thuong Thi Huyen; Hung Manh; Hang Le Bich Pham; Ton Dang Nguyen; Hien Thi Thu Le; Hai Van Nong
Journal:  Mol Vis       Date:  2018-03-17       Impact factor: 2.367

8.  Gene expression profiling identifies different sub-types of retinoblastoma.

Authors:  G Kapatai; M-A Brundler; H Jenkinson; P Kearns; M Parulekar; A C Peet; C M McConville
Journal:  Br J Cancer       Date:  2013-06-11       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.